Registry for Systemic Eczema Treatments

Description

The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.

Conditions

Atopic Dermatitis

Talk to us

Study Overview

On this page

Study Details

Study overview

The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.

Registry for Systemic Eczema Treatments

Registry for Systemic Eczema Treatments

Condition
Atopic Dermatitis
Intervention / Treatment

-

Contacts and Locations

Baltimore

Johns Hopkins University, Baltimore, Maryland, United States, 21218

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age \<26 years old
  • * Current physician diagnosis of atopic dermatitis
  • * Provide signed informed consent if ≥ 18 years old
  • * Provide signed informed consent by parent or legal guardian (if \<18 years old) and informed assent if applicable
  • * Subject and/or parent/legal guardian is willing to be contacted in the future by study staff
  • * Seen for clinical care at Johns Hopkins since 1/1/2017
  • * Previously on, currently on, or planning to initiate (within next 6 months) a systemic AD therapy
  • * Age ≥26 years old at the time of registry enrollment
  • * Does not speak English
  • * If \<18 years old, has a primary caretaker who does not speak English
  • * If \<18 years old, parent/legal guardian is unwilling to sign the written informed consent
  • * Is a foster child
  • * Has not received clinical care at Johns Hopkins since 1/1/2017

Ages Eligible for Study

1 Year to 26 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Johns Hopkins University,

Joy Wan, MD MSCE, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

2026-12-31